Korean AIDS patients and activists calling for compulsory license of Fuzeon

Published: 2008-09-22 06:50:00

Updated: 2008-09-22 06:50:00

Korea should move a step closer to breaking the drug patent of Fuzeon by asking the Swiss drug giant Roche for the right to copy the product so the country can slash medication costs, according to Korean AIDS patients and civil groups.

Under Korean law, and based on World Trade Organization ru...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK